TOKYO--(BUSINESS WIRE)--#drugdiscovery--Chugai Pharmaceutical Co., Ltd. (TOKYO:4519): Outline Osaka University and Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) today announced the conclusion of a comprehensive collaboration agreement for advanced research in immunology between the Osaka University Immunology Frontier Research Center (IFReC) and Chugai. IFReC was selected for the World Premier International Research Center (WPI) Initiative Program initiated by the Ministry of Education, Culture, Sports, Science
![]()
↧